FEB 08, 2017 12:25 PM PST

Two B Cells Types, Two Completely Different Life Roles

WRITTEN BY: Kara Marker

A specialized form of immune B cells exist in the human spleen to protect the body from specific types of bacteria. But there is a unique molecular process that needs to happen in order for immature B cells to become these specialized cells over other types of cells.

From The Flanders Institute for Biotechnology (VIB), researchers investigated the pathways behind the differentiation of specialized B cells called MZB cells, named for the marginal zone in the spleen where they congregate. The spleen plays the important role of filtering the blood for bacteria and other foreign particles. 

A  section taken from a spleen reveals splenic tissue with sheets of immune cells. Source: Cytopath Veterinary Pathology Laboratory

MZB cells are involved in antibody “training” to prepare them for the fight against infectious disease, mainly producing antibodies that target encapsulated bacterial like pneumococcus. However, MZB cells are not the only immune cells doing work in the spleen. They share some space with another B cell subtype called follicular B cells, so what makes precursor cells “decide” to become MZB cells versus follicular B cells?

"We had a 'eureka!' moment after discovering that a little-known protein, Taok3, brings a certain proteinase, ADAM10, to the surface of the immature B cell that triggers its development into an MZB cell,” explained VIB’s Hamida Hammad. “Without that special event, immature B cells can only develop into follicular B cells." Hammad and the team from VIB started their study with the knowledge that Taok3 protein triggers, somehow, the development of MZB cells.

Identifying the role of Taok3 protein in the development of MZB cells provides new possibilities for treatments of genetic conditions, asthma, and diabetes, which might rely on the immune response which includes MZB cells.

VIB researchers confirmed the role of Taok3 in mice studies by removing the Taok3 gene. Without it, the mice would make almost any B cell type except MZB cells. They were also especially susceptible to respiratory infection from pneumococcus bacteria.

"With an abundance of only follicular B cells, Taok3-free mice are less capable of fighting these types of bacteria effectively,” Hammad said.

“This research has generated insights that are very relevant to new therapies to a range of important diseases,” said VIB’s Bart Lambrecht. “It goes to show that basic science sometimes leads to unexpected - and important - applications."

The VIB’s new study was published in the journal Nature Immunology.

Source: The Flanders Institute for Biotechnology (VIB)

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
APR 29, 2021
Immunology
A Week for World Immunization
APR 29, 2021
A Week for World Immunization
The World Health Organization (WHO) is calling our attention to World Immunization Week, which comes in the last week of ...
MAY 22, 2021
Drug Discovery & Development
Drug Combo Treats 86% of Patients with Gout
MAY 22, 2021
Drug Combo Treats 86% of Patients with Gout
Researchers at the University of Michigan have found that a combination of two drugs is twice as effective as current tr ...
Loading Comments...